Tag: Myocardial Infarctions
-
Tasigna Lawsuits Federal Court MDL Order Issued in August 2021 After July 2021 JPML Hearing
Consolidation of Tasigna Drug Injury Cases Involving Atherosclerosis-related Diseases and Medical Conditions (Posted by Tom Lamb at Drug Injury Watch) On August 12, 2021, the United States Judicial Panel on Multidistrict Litigation (JPML) created a…
-
New Medical Evidence Suggests Pradaxa And Xarelto May Double The Risk Of Heart Attacks In Atrial Fibrillation Patients
An Observational Study Compared Myocardial Infarction / Heart Attack Risks As Between The Use Of Newer Blood Thinners And The Use Of Warfarin (Posted by Tom Lamb at DrugInjuryWatch.com) In the US,…
-
For Testosterone Therapy Drugs Like AndroGel / Axiron / Testim: Add “Black-Box” Warning To Label: Public Citizen’s Petition To FDA
Earlier In February 2014 The Endocrine Society Of Medical Doctors Urged Caution In The Prescribing Of These Products To Certain Middle-Aged And Older Men (Posted by Tom Lamb at DrugInjuryWatch.com)On February 25, 2014 a so-called Citizen Petition…
-
The Growing Use Of Testosterone Creams, Gels, Injections, And Patches Raises Increased Concerns About Risks Of Cardiac Side Effects
Critics Of "Low-T" Drugs Like Axiron, AndroGel, And Testim Blame Medically Unnecessary Use Of Androgen Therapy On Drug Company Advertising (Posted by Tom Lamb at DrugInjuryWatch.com)______________________________________________________________________________ UPDATE: "FDA evaluating risk of stroke, heart attack and…
-
Increasing Number Of Pradaxa Lawsuits Against Boehringer Are Consolidated In Federal Court MDL
This Pradaxa MDL Case Will Include Gastrointestinal Bleeding And Other Hemorrhages As Well As Heart Attacks Or Myocardial Infarctions (Posted by Tom Lamb at DrugInjuryWatch.com) Pradaxa is a blood-thinning drug used to reduce the risk of…
-
Safety Profile Of New Stroke Drug Pradaxa Has Been Tarnished By Various Adverse Event Reports
FDA Reviewing Serious Side Effects Associated With Pradaxa Ranging From Heart Attacks To Serious Bleeding or Hemorrhages (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: Pradaxa label change: This January 17, 2012 FDA approval letter shows…